Literature DB >> 16850479

Tissue-engineered tear secretory system: functional lacrimal gland acinar cells cultured on matrix protein-coated substrata.

Shivaram Selvam1, Padmaja B Thomas, Melvin D Trousdale, Douglas Stevenson, Joel E Schechter, Austin K Mircheff, Jean T Jacob, Ronald E Smith, Samuel C Yiu.   

Abstract

Dry eye is a general term that refers to a myriad of ophthalmic disorders resulting in the inadequate wetting of the corneal surface by the tear film. Dry eyes are typically treated by the application of artificial tears. However, patients with lacrimal insufficiencies such as Stevens-Johnson syndrome, chemical and thermal injuries, or ocular cicatricial pemphigoid have very limited options because of the short duration and action of lubricating agents. As a therapeutic strategy, we are working to develop a bioengineered tear secretory system for such patients. This article describes the growth and physiological properties of purified rabbit lacrimal gland acinar cells (pLGACs) on several matrix protein-coated polymers such as silicone, collagen I, copolymers of poly-D,L-lactide-co-glycolide (PLGA; 85:15 and 50:50), poly-L-lactic acid (PLLA), and Thermanox plastic cell culture coverslips. Monolayers of acinar cells were established on all of the polymeric substrata. An assay of beta-hexosaminidase activity in the supernatant medium showed significant increases in protein secretion, following stimulation with 100 microM carbachol on matrix protein-coated and uncoated polymers such as silicone, PLGA 85:15, and PLLA. Our study demonstrates that PLLA supported the morphological and physiological properties of purified rabbit lacrimal gland epithelial cells more successfully than the others. 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16850479     DOI: 10.1002/jbm.b.30584

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  7 in total

Review 1.  Current status of gene delivery and gene therapy in lacrimal gland using viral vectors.

Authors:  Shivaram Selvam; Padmaja B Thomas; Sarah F Hamm-Alvarez; Joel E Schechter; Douglas Stevenson; Austin K Mircheff; Melvin D Trousdale
Journal:  Adv Drug Deliv Rev       Date:  2006-09-15       Impact factor: 15.470

Review 2.  Lacrimal gland development: From signaling interactions to regenerative medicine.

Authors:  Ankur Garg; Xin Zhang
Journal:  Dev Dyn       Date:  2017-08-18       Impact factor: 3.780

3.  Microporous poly(L-lactic acid) membranes fabricated by polyethylene glycol solvent-cast/particulate leaching technique.

Authors:  Shivaram Selvam; Wenji V Chang; Tamako Nakamura; Deedar M Samant; Padmaja B Thomas; Melvin D Trousdale; Austin K Mircheff; Joel E Schechter; Samuel C Yiu
Journal:  Tissue Eng Part C Methods       Date:  2009-09       Impact factor: 3.056

Review 4.  Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases.

Authors:  Darlene A Dartt
Journal:  Prog Retin Eye Res       Date:  2009-04-17       Impact factor: 21.198

5.  Amniotic membrane as a carrier for lacrimal gland acinar cells.

Authors:  S Schrader; Th Wedel; C Kremling; H Laqua; G Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-06-12       Impact factor: 3.117

6.  Characterization of cultivated murine lacrimal gland epithelial cells.

Authors:  Shinya Kobayashi; Tetsuya Kawakita; Motoko Kawashima; Naoko Okada; Kenji Mishima; Ichiro Saito; Masataka Ito; Shigeto Shimmura; Kazuo Tsubota
Journal:  Mol Vis       Date:  2012-05-12       Impact factor: 2.367

7.  An In Vitro Model for the Ocular Surface and Tear Film System.

Authors:  Qiaozhi Lu; Hongbo Yin; Michael P Grant; Jennifer H Elisseeff
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.